Diffusion-weighted imaging in Huntington's disease

被引:39
作者
Seppi, Klaus [1 ]
Schocke, Michael F. H.
Mair, Katherina J.
Esterhammer, Regina
Weirich-Schwaiger, Helga
Utermann, Barbara
Egger, Karl
Brenneis, Christian
Granata, Roberta
Boesch, Sylvia
Poewe, Werner
Wenning, Gregor K.
机构
[1] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Radiol 1, Innsbruck, Austria
[3] Innsbruck Med Univ, Inst Med Biol & Human Genet, Innsbruck, Austria
关键词
Huntington's disease; striatum; magnetic resonance imaging; diffusion-weighted imaging;
D O I
10.1002/mds.20868
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder that results from an expanded trinucleotide (CAG) repeat on the huntingtin gene. Neurodegeneration in HD affects most prominently the basal ganglia. Therefore, diffusivity was obtained in the basal ganglia and thalamus of 29 patients with early HD and 27 healthy volunteers by means of the trace of the diffusion tensor (Trace(D)). Putaminal, caudate, pallidal, and thalamic Trace(D) values were increased in patients with HD compared with controls. Increased diffusivity in the putamen and caudate nucleus correlated with global functional impairment, CAG repeat length, as well as bicaudate ratio. Diffusion-weighted imaging appears to be a promising surrogate marker for disease severity in HD. Sensitivity to change remains to be established longitudinally. (C) 2006 Movement Disorder Society.
引用
收藏
页码:1043 / 1047
页数:5
相关论文
共 36 条
[1]
[11C]raclopride-PET studies of the Huntington's disease rate of progression:: Relevance of the trinucleotide repeat length [J].
Antonini, A ;
Leenders, KL ;
Eidelberg, D .
ANNALS OF NEUROLOGY, 1998, 43 (02) :253-255
[2]
Striatal glucose metabolism and dopamine D-2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease [J].
Antonini, A ;
Leenders, KL ;
Spiegel, R ;
Meier, D ;
Vontobel, P ;
WeigellWeber, M ;
SanchezPernaute, R ;
deYebenez, JG ;
Boesiger, P ;
Weindl, A ;
Maguire, RP .
BRAIN, 1996, 119 :2085-2095
[3]
AYLWARD EH, 1991, AM J NEURORADIOL, V12, P1217
[4]
Longitudinal change in basal ganglia volume in patients with Huntington's disease [J].
Aylward, EH ;
Li, Q ;
Stine, OC ;
Ranen, N ;
Sherr, M ;
Barta, PE ;
Bylsma, FW ;
Pearlson, GD ;
Ross, CA .
NEUROLOGY, 1997, 48 (02) :394-399
[5]
BIGLAN KM, 2002, PARKINSONS DIS MOVEM, P212
[6]
Chun T, 2000, AM J NEURORADIOL, V21, P1078
[7]
Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease [J].
Furtado, S ;
Suchowersky, O ;
Rewcasle, NB ;
Graham, L ;
Klimek, ML ;
Garber, A .
ANNALS OF NEUROLOGY, 1996, 39 (01) :132-136
[8]
Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease [J].
Harris, GJ ;
Aylward, EH ;
Peyser, CE ;
Pearlson, GD ;
Brandt, J ;
RobertsTwillie, JV ;
Barta, PE ;
Folstein, SE .
ARCHIVES OF NEUROLOGY, 1996, 53 (04) :316-324
[9]
POSITRON EMISSION TOMOGRAPHY IN THE EARLY DIAGNOSIS OF HUNTINGTONS-DISEASE [J].
HAYDEN, MR ;
MARTIN, WRW ;
STOESSL, AJ ;
CLARK, C ;
HOLLENBERG, S ;
ADAM, MJ ;
AMMANN, W ;
HARROP, R ;
ROGERS, J ;
RUTH, T ;
SAYRE, C ;
PATE, BD .
NEUROLOGY, 1986, 36 (07) :888-894
[10]
Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease [J].
Heinsen, H ;
Rüb, U ;
Bauer, M ;
Ulmar, G ;
Bethke, B ;
Schüler, M ;
Böcker, F ;
Eisenmenger, W ;
Götz, M ;
Korr, H ;
Schmitz, C .
ACTA NEUROPATHOLOGICA, 1999, 97 (06) :613-622